Comprehensive Non-Surgical Treatment of Varicose Veins: Advanced Techniques for Vascular Surgeons

Varicose veins are a prevalent venous disorder, often resulting in symptoms like aching, swelling, and skin changes, and can significantly impact a patient’s quality of life . With the evolution of minimally invasive treatments, vascular surgeons now have an array of non-surgical options that provide effective outcomes with fewer complications and shorter recovery times compared to traditional vein stripping . This detailed review explores the latest advancements in non-surgical treatments, offering insights into their mechanisms, indications, benefits, and limitations for clinical practice .

Endovenous Laser Ablation (EVLA)

Mechanism : Endovenous laser ablation (EVLA) uses ultrasound guidance to insert a laser fiber into the saphenous vein. The laser emits thermal energy, causing vein wall contraction and eventual fibrosis.

Indications :

Great saphenous vein (GSV) incompetence
Small saphenous vein (SSV) incompetence
Perforator veins

Procedure Details :

Performed under tumescent anesthesia
Laser wavelengths (810, 940, 980, 1470 nm) with radial fibers offer improved outcomes
Energy settings range between 60-100 J/cm

Benefits :

High occlusion rates (95%-98%)
Outpatient procedure with minimal downtime
Reduced postoperative pain with modern wavelength lasers

Limitations :

Risk of thermal injury to surrounding tissues
Potential for recanalization in some cases
Superficial phlebitis

Radiofrequency Ablation (RFA)

Mechanism : RFA involves the delivery of radiofrequency energy through a catheter, generating heat (120°C) that leads to collagen contraction and vein closure . Catheters like the ClosureFAST system ensure even heating .

Indications :

Incompetent saphenous veins
Perforator vein incompetence

Procedure Details :

Tumescent anesthesia used to create a thermal barrier and compress the vein
Segmental ablation allows uniform heat application over 20-second cycles

Benefits :

Comparable efficacy to EVLA with less postoperative pain
Higher patient satisfaction due to minimal bruising and quicker return to activities
Success rates over 95% at three years

Limitations :

Requires more significant capital investment for the RFA generator
Vein diameter may limit effectiveness; larger veins may need adjunct treatments

Ultrasound-Guided Foam Sclerotherapy (UGFS)

Mechanism : UGFS uses a sclerosant foam (polidocanol or sodium tetradecyl sulfate) injected into the vein under ultrasound guidance , causing endothelial damage , inflammation , and subsequent vein obliteration .

Indications :

Residual varicose veins post-EVLA/RFA
Recurrent varicose veins
Patients unsuitable for thermal ablation

Procedure Details :

Foam preparation using the Tessari or double-syringe technique
Concentration of sclerosant (0.5%-3%) based on vein size and location

Benefits :

Can treat tortuous veins not amenable to straight catheter-based techniques
Performed in an outpatient setting without anesthesia
Minimal equipment requirements

Limitations :

Higher recurrence rates compared to thermal ablation
Risk of visual disturbances, transient ischemic attacks (TIAs) in susceptible individuals
Requires repeat sessions for complete vein closure

Venaseal Closure System

Mechanism : The Venaseal system delivers a cyanoacrylate adhesive into the vein lumen, leading to immediate closure via polymerization and adhesion of the vein walls.

Indications :

Saphenous vein incompetence
Patients contraindicated for tumescent anesthesia

Procedure Details :

Performed without tumescent anesthesia or post-procedure compression stockings
The adhesive is delivered via a catheter, guided by ultrasound

Benefits :

Immediate vein closure without heat or sclerosant
No need for tumescent anesthesia reduces procedure time
Reduced post-operative pain and no need for compression stockings

Limitations :

Potential for phlebitis at the treatment site
Limited long-term data compared to EVLA and RFA
Higher initial cost of the adhesive material

Mechanochemical Ablation (MOCA)

Mechanism: MOCA combines mechanical disruption of the vein endothelium with simultaneous administration of a sclerosant . Devices like the ClariVein system use a rotating catheter tip for mechanical injury .

Indications:

Great and small saphenous vein incompetence
Patients desiring a non-thermal , non-tumescent option

Procedure Details :

Sclerosant (e.g., polidocanol) is infused while the rotating catheter disrupts the endothelium
No need for tumescent anesthesia

Benefits :

No thermal injury risk
Minimal pain and bruising
Rapid recovery and high patient satisfaction

Limitations :

Limited to veins up to 12 mm in diameter
Lack of long-term efficacy data compared to thermal ablation
Requires specific equipment and training

Clinical Decision-Making and Patient Selection

The choice of treatment depends on several factors , including vein anatomy , patient comorbidities , preferences , and available resources . Comprehensive duplex ultrasound evaluation is essential for mapping venous insufficiency and guiding treatment selection . In many cases , combining different modalities (e.g., EVLA with UGFS) offers superior outcomes .

Modern non-surgical treatments for varicose veins provide vascular surgeons with effective , patient-centered approaches to managing venous insufficiency . Each technique has its advantages and limitations , requiring careful patient selection and procedural expertise . As these technologies continue to evolve , vascular surgeons must stay abreast of advancements to offer the best care options tailored to individual patient needs .

Thank you for visiting our website. If you have any questions or need more information, please feel free to contact us.

Conditions We Treat

Quick Links

OPD Timing

MONDAY TO SATURDAY -	9 AM TO 5 PM

Contact Us

All rights reserved. Powered by Codingclave Technologies.